Phase I-II Trial of Glasdegib in Myelofibrosis - Glasdegib is a Hedgehog Pathway Inhibitor - 101931

Spotlight
Video

Phase I-II Trial of Glasdegib in Myelofibrosis - Glasdegib is a Hedgehog Pathway Inhibitor

ASHReport has 256 videos Subscribe Here

Loading........
Description: Aaron Gerds, MD from Cleveland Clinics discusses phase I-II trial of Glasdegib in myelofibrosis and that Glasdegib is a Hedgehog Pathway Inhibitor at the 2017 American Society of Hematology.
Shared By : ASHReport
Posted on : 01/24/18
Added : 24 days ago



Recommended

Nothing found.

More From ASHReport

Nothing found.